USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
LIBREDE, INC.
Address:
14819 Sutton St.
Sherman Oaks, CA
Phone:
N/A
URL:
N/A
EIN:
126309424
DUNS:
828873021
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $722,312.00 5
SBIR Phase II $2,330,658.00 2

Award List:

Development of a disposable shippable chip for high throughput ion channel screen

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$130,465.00
Agency:
HHS
Principal Investigator:
Jason L. Poulos
Abstract:
DESCRIPTION (provided by applicant): Ion channels are important drug targets and unintended drug interactions with ion channels are also of critical importance, requiring the screening of all drug candidates. Conventional high throughput screening processe s for soluble proteins are problematic to… More

Instrumentation Development for Parallel Measurement of an Ion Channel Array Chip

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$128,332.00
Agency:
HHS
Principal Investigator:
Jason Poulos
Abstract:
DESCRIPTION (provided by applicant): Electrophysiological assays of ion channels for pharmaceutical discovery and safety screening are problematic to perform in high throughput because the ion channels must be incorporated into a lipid bilayer membrane to enable measurement of their ionic… More

SBIR Phase I: Development of new materials for a low cost high throughput ion channel measurement platform

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$149,770.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project will support the development of a novel ion channel measurement platform. Ion channels are important in a wide range of physiological processes including cardiac and neural activity. The technology is centered on inexpensively… More

Droplet-based artificial membrane technology for high throughput cell-free ion ch

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$163,750.00
Agency:
HHS
Principal Investigator:
Jason Poulos – 858-349-6779
Abstract:
DESCRIPTION (provided by applicant): Ion channels pharmaceutical discovery and safety screening is slow and expensive and as a result, there are currently no high quality, high throughput assays for ion channel screening. Librede Inc. is developing alternative cell-free technologies for ion channel… More

Development of a disposable cell-free ion channel measurement platform for hERG s

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$777,827.00
Agency:
HHS
Principal Investigator:
Jason Poulos – 858-349-6779
Abstract:
DESCRIPTION (provided by applicant): Assaying ion channels for pharmaceutical discovery and safety screening is problematic to perform in high throughput because the ion channels must be incorporated into a cell membrane to allow measurement of their ionictransport to determine their functionality.… More

High throughput cell-free ion channel screening workstation

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,552,831.00
Agency:
HHS
Principal Investigator:
Jason Poulos – 858-349-6779
Abstract:
DESCRIPTION (provided by applicant): Ion channels are important drug targets-present in every cell, they play key roles in a wide range of physiological processes including the cardiac cycle and neural activity. As a result, unintended drug interactions with ion channels are also of critical… More

SBIR Phase I: Development of a 32 site ion channel measurement consumable

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$149,995.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I project is aimed at developing improved technology for drug discovery and safety screening of ion channels. Ion channels are present in every cell and play key roles in a wide range of physiological processes including the cardiac cycle and neural… More